LabGenius Therapeutics
PrivateLast Round
Series B
Extension
Feb 16, 2026
Total Funding Raised
$78.1M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
LabGenius Therapeutics is a biotechnology company that develops an AI-driven protein engineering platform to discover and optimize next-generation therapeutic antibodies for solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LabGenius Therapeutics Comparables
Compare LabGenius Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BigHat Biosciences | 88% | |
| Generate Biomedicines | 83% | |
| AbCellera Biologics Inc. | 83% |
LabGenius Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Feb 16, 2026 | ||||
| Series B | May 21, 2024 | ||||
| Grant | Nov 30, 2022 | ||||
| Grant | Oct 7, 2022 | ||||
| Series A Extension | Oct 29, 2020 | ||||
Series A | Oct 24, 2019 |
LabGenius Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Backed VC | Seed |
| Beast Mode | Seed |
| System.One | Seed |
| Inovia Capital | Series A, Series A Extension |
| Air Street Capital | Series A |
| Acequia Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 95% MoM, reaching 4.2K.
- Apr 25, 2026
Monthly visitors increased 180% MoM, reaching 3.1K.
LabGenius Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about LabGenius Therapeutics's valuation, stock price, and market status.
Is LabGenius a public or private company?
LabGenius is a private company.
What is the current stock price of LabGenius?
LabGenius is a private company with no public stock price. No recent secondary market data is available.
How much is LabGenius worth (valuation)?
Valuation information for LabGenius is not publicly available.
Can I buy LabGenius stock?
LabGenius shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was LabGenius's last funding round?
LabGenius's most recent funding round was Series B on May 21, 2024.
Who are the main investors in LabGenius?
Key investors in LabGenius include Lux Capital, Obvious Ventures, Kindred Capital, Atomico, Acequia Capital.
Will LabGenius IPO soon?
No public IPO plans have been announced for LabGenius.
How can I track LabGenius secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor LabGenius's secondary market activity and sign up for updates.